Top insider buys and sells disclosed on Friday

Relmada Therapeutics (RLMD) executives bought shares at $4.10-$4.25. PVH (PVH) CEO bought $1M in stock. Clipper Realty (CLPR) director bought $388K in shares. Gloo (GLOO) chair bought 50,000 shares. Hagerty (HGTY) sold $122M in shares. Dell (DELL) saw $55M in sales by Silver Lake. Hinge Health (HNGE) CEO sold $22.3M in shares.

Original reporting
Published Sep 14, 2026, 1:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RLMD
Bullish
medium confidence
Mentioned
$RLMD · $PVH · $CLPR · $GLOO · $HGTY · $DELL
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$RLMDBullishLow
01

Why it matters

While some insiders are adding to positions, several major shareholders are divesting sizable stakes, creating mixed signals for traders.

02

Market read

The filings provide fresh data for traders monitoring insider sentiment, but the overall market impact is limited.

03

What to watch

Buy‑side actions (Relmada, PVH) may reflect strategic positioning not captured by price alone.

Relevance 4/10Novelty 3/10Timing: Friday disclosure

Background

The article aggregates recent Form 4 filings, highlighting notable insider purchases and sales for a set of U.S. listed companies.

Company-level read

Ticker impact

$RLMDBullishMedium confidence
Context

CEO and CFO of Relmada Therapeutics bought shares worth $1.67M over two days, indicating confidence in the micro‑cap biotech.

Expected impact

Potential modest upside of 5‑10% if buying continues.

Evidence & confidence

Buyers are top executives; purchase size is notable relative to market cap.

$PVHBullishMedium confidence
Context

PVH CEO purchased $1M of stock as the share price had fallen 5% over the week, suggesting belief in undervaluation.

Expected impact

Possible short‑term rally of 3‑5%.

Evidence & confidence

CEO buying after a recent decline often signals confidence.

$CLPRBullishLow confidence
Context

Director/10% owner bought $388k of Clipper Realty, adding to his stake amid a 5.6% weekly gain.

Expected impact

Limited upside, 2‑4% support level.

Evidence & confidence

Purchase size modest relative to market cap.

$GLOOBullishLow confidence
Context

Executive chair bought 50k shares ($166.9k) while the stock sits near a 67% drop from its 52‑week high.

Expected impact

Potential stabilization, 3‑6% bounce.

Evidence & confidence

Small purchase relative to float; stock heavily depressed.

$HGTYBearishMedium confidence
Context

10% owner sold 10.6M shares for $122M, a large divestiture after the stock rose to $13.55.

Expected impact

Possible downside of 5‑8% on near‑term.

Evidence & confidence

Sizeable sell by a major shareholder often signals concerns.

$DELLBearishMedium confidence
Context

Silver Lake affiliates sold roughly $55M of Dell Class C shares across two filings, indicating possible valuation concerns.

Expected impact

Potential short‑term dip of 3‑6%.

Evidence & confidence

Large sell by a 10% owner; stock near 52‑week high.

$HNGEBearishMedium confidence
Context

CEO and spouse sold $22.3M of Hinge Health shares under a 10b5‑1 plan as the stock nears its 52‑week high.

Expected impact

Possible pullback of 4‑7%.

Evidence & confidence

Large sell amount; timing coincides with peak price.

Market effects

Insider activity across biotech, apparel, REIT, software, insurance, and tech may hint at sector‑wide confidence shifts.

Primarily U.S. equities; limited broader market effect.

Low global impact; isolated to individual stocks.

Counterpoint

Large insider sells (Dell, Hagerty, Hinge Health) could signal overvaluation despite recent price gains.

Key entities

  • Relmada Therapeutics, Inc.

    Biotech firm with recent insider buying.

  • Dell Technologies Inc.

    Technology hardware maker with large insider sell.

Related articles

$NVDAMed

Asia's chip smuggling fears put Malaysia, Thailand and Singapore in the US firing line

The US Commerce Department will require licenses for shipments of advanced chips to Malaysia, Thailand, Singapore, Indonesia, and Brazil from November 19, citing risks of diversion to Chinese firms. The rule aims to prevent circumvention of US tech restrictions through foreign data centers. Malaysia and Thailand have significant data-center capacity under construction, with US and Chinese companies involved. Nvidia's H100 processors are mentioned as a benchmark for the new regulations.

$DELLMed

Pashinyan, Dell Technologies EMEA President Discuss Expanding Cooperation in Armenia

Armenian PM Pashinyan met with Dell Technologies EMEA President McDonald to discuss expanding cooperation. Pashinyan emphasized the importance of broadening ties, citing potential for new investment projects. Dell's existing initiative in Armenia includes a $500M AI data center partnership with Firebird. Both sides agreed to continue discussions on future joint initiatives.

$NVDAMed

Nvidia Shakeup Sends AI Stocks Tumbling

Nvidia's shares dropped 29% after CEO Jensen Huang was removed due to an affair. The company reported solid results, raised its outlook, and expanded its buyback program. AI-related stocks, including Neocloud operators and data center gear makers, also fell. Competitors like Broadcom and AMD saw mixed reactions. Investors are concerned about AI spending and leadership uncertainty.

$DELLMedAI 8/10

Dell Technologies sinks 12% amid tech slide

Dell Technologies (DELL) shares fell 12% to $275.47 on Friday, coinciding with a broader tech sector selloff. The company's stock is down 31.38% over one month, trading below key moving averages. Analysts cite weaker demand, AI uncertainty, and margin concerns as factors. Dell's forward P/E is 12.08, and forward PEG is 0.31, but demand sustainability and valuation remain uncertain.

$DELLHigh

Why is Dell Technologies stock sliding today?

Dell Technologies' stock fell 6.7% to $291.75 due to investor anxiety over Nvidia's leadership changes and AI sector sell-off. Analysts cut price targets, citing margin concerns. The stock is down 25% in November, with earnings due November 24. Broader market declines and pre-earnings caution also contributed to the drop.

$HNGEMed

The Zacks Analyst Blog Highlights Hinge Health, OPKO Health, Globus Medical and Merit Medical Systems

Hinge Health (HNGE) stock surged 146.3% YTD, outperforming the industry and S&P 500. Q3 revenue grew 52% YoY to $235M, with operating margin expanding to 33%. The company raised 2026 revenue guidance to $879-$881M. Growth is driven by member engagement, AI efficiencies, and expansion into migraine and GI care. Risks include execution challenges in new care categories. Zacks ranks HNGE as Strong Buy.